YM155 Inhibits Neuroblastoma Cell Migration and Survival <i>in Vitro</i> and Tumor Growth and Metastatic Burden in a Pre-Clinical Model

Journals Menu

Follow SCIRP

ISSN Print: 2151-1934
ISSN Online: 2151-1942
www.scirp.org/journal/jct
E-mail: jct@scirp.org

Citations h5-index & Ranking

"YM155 Inhibits Neuroblastoma Cell Migration and Survival in Vitro and Tumor Growth and Metastatic Burden in a Pre-Clinical Model"
written by Heather M. Calderone, Akshita Dutta, Lauren Smith, Alexandra Eckardt, Ping Zhao, Giselle Saulnier Sholler,
published by Journal of Cancer Therapy, Vol.5 No.13, 2014

has been cited by the following article(s):

[1]	Lapatinib potentiates cytotoxicity of YM155 in neuroblastoma via inhibition of the ABCB1 efflux transporter
	Scientific Reports, 2017

[1]	The molecular basis of tumor metastasis and current approaches to decode targeted migration-promoting events in pediatric neuroblastoma Biochemical Pharmacology, 2023 DOI:10.1016/j.bcp.2023.115696

[2]	The molecular basis of tumor metastasis and current approaches to decode targeted migration-promoting events in pediatric neuroblastoma Biochemical Pharmacology, 2023 DOI:10.1016/j.bcp.2023.115696

[3]	Lapatinib potentiates cytotoxicity of YM155 in neuroblastoma via inhibition of the ABCB1 efflux transporter Scientific Reports, 2017 DOI:10.1038/s41598-017-03129-6

[4]	Lapatinib potentiates cytotoxicity of YM155 in neuroblastoma via inhibition of the ABCB1 efflux transporter Scientific Reports, 2017 DOI:10.1038/s41598-017-03129-6

Follow SCIRP